Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain.
Chaikuad, A., Lang, S., Brennan, P.E., Temperini, C., Fedorov, O., Hollander, J., Nachane, R., Abell, C., Muller, S., Siegal, G., Knapp, S.(2016) J Med Chem 59: 1648-1653
- PubMed: 26731131 
- DOI: 10.1021/acs.jmedchem.5b01719
- Primary Citation of Related Structures:  
5FE1, 5FE0, 5FE3, 5FE2, 5FE5, 5FE4, 5FE7, 5FE6, 5FE9, 5FE8 - PubMed Abstract: 
The P300/CBP-associated factor plays a central role in retroviral infection and cancer development, and the C-terminal bromodomain provides an opportunity for selective targeting. Here, we report several new classes of acetyl-lysine mimetic ligands ranging from mM to low micromolar affinity that were identified using fragment screening approaches ...